- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Carl Zeiss Meditec eyes surgical sister company
Jena, Germany—Carl Zeiss Meditec AG said a plan to acquire Carl Zeiss Surgical will expand its role in ophthalmic and neuro/ ENT surgery.
Jena, Germany-Carl Zeiss Meditec AG said a plan to acquire Carl Zeiss Surgical will expand its role in ophthalmic and neuro/ ENT surgery.
In a Jan. 9 news release, the device manufacturer said the acquisition-pending approval at the annual general meeting of Carl Zeiss Meditec AG this month-would make Carl Zeiss Meditec a leading medical technology provider in those specialty areas. Sales would be about Euro 500 million, the company said.
Carl Zeiss Surgical, a manufacturer of surgical microscopes and visualization solutions, is based in Oberkochen, Germany, and serves the U.S. market from an office in Thornwood, NY. It is wholly owned by Carl Zeiss AG, which also owns 65% of Carl Zeiss Meditec. Carl Zeiss Meditec is based in Jena, Germany, with key subsidiaries in the United States and Japan.
